logo
 
Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated (double dose) with either Covishield or Covaxin. This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
 
The Union Health Ministry's approval is based on the recommendations made recently by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).

"Corbevax will be considered as a precaution



dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those aged above 18 years enabling use of  Corbevax as a heterologous COVID-19 vaccine for precaution dose administration in this age group," the sources said.

This will be in addition to the existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine, the sources added. All necessary changes in regard to the administration of the precaution dose of Corbevax vaccine are being made on the Co-WIN portal.
No Comments For This Post, Be first to write a Comment.
Leave a Comment
Name:
Email:
Comment:
Enter the code shown:


Can't read the image? click here to refresh

Todays Epaper

neerus indian ethnic wear
Latest Urdu News

Do you think, Telangana CM KCR can be successful after launching the new national party?

Yes
No
Can't Say